First-line cabozantinib declined for a second time for use within NHS Scotland
Cabozantinib has been declined for a second time by the [...]
World Cancer Day
Today (4th February) is World Cancer Day, and KCSN are [...]
Real world evidence as a complement to clinical trials
The review article highlights the usefulness of real world evidence [...]
NHS Long Term Plan launched today
The new NHS Long Term Plan is published today with [...]
Tivozanib expected to be included in European clinical practice guidelines for advanced kidney cancer
Tivozanib is expected to be included as a first-line treatment [...]
NICE publishes final guidance for cabozantinib for untreated advanced renal cell carcinoma
The National Institute for Health and Care Excellence (NICE) has published final [...]
Advanced Kidney Cancer Centre of Excellence
The Advanced Kidney Cancer Center of Excellence from UroToday and [...]
Tips to help with mental wellbeing for people with cancer
The following blog, on the Patient Empowerment Network, gives some [...]
IKCC statement on the negative opinion by the CHMP for the ipilimumab/nivolumab combination
The International Kidney Cancer Coalition (IKCC) have released the following [...]
NHS performs worse than average for major causes of death
A recent report from the Nuffield Trust, the Health Foundation, [...]
